Tributes pour in for Richard Scolyer, renowned cancer researcher who passed away at 59
Richard Scolyer, cancer researcher and former Australian of the year, dies aged 59
The Guardian
Image: The Guardian
Richard Scolyer, a prominent cancer researcher and former Australian of the Year, has died at 59 after battling brain cancer. He expressed gratitude to supporters and hoped to inspire others through his journey. His work significantly advanced melanoma treatment and impacted cancer patients globally.
- 01Scolyer was diagnosed with grade-four inoperable brain cancer in May 2023, with a prognosis of six to eight months.
- 02He underwent innovative immunotherapy treatments, which initially slowed the cancer's progression.
- 03In 2024, he was jointly named Australian of the Year for his contributions to cancer research alongside Georgina Long.
- 04Scolyer received the New South Wales Premier’s Award for Outstanding Cancer Research nine times and was appointed an Officer of the Order of Australia in 2021.
- 05His legacy includes inspiring others to pursue their dreams with humility and compassion.
Advertisement
In-Article Ad
Professor Richard Scolyer, a distinguished cancer researcher and former Australian of the Year, has passed away at the age of 59 after a battle with brain cancer. In a heartfelt statement before his death, Scolyer thanked the Australian public for their support, reflecting on his journey and expressing hope that his experiences would make life easier for others facing similar challenges. Diagnosed with grade-four inoperable brain cancer in May 2023, he initially faced a grim prognosis but underwent groundbreaking immunotherapy treatments that slowed the disease's progression. Despite the cancer's return, he maintained a positive outlook, sharing updates with his extensive online community. Scolyer's contributions to melanoma research, particularly through his work at the Melanoma Institute Australia, led to him receiving numerous accolades, including the New South Wales Premier’s Award for Outstanding Cancer Research and the title of Australian of the Year in 2024. His legacy will be remembered for inspiring countless individuals and advancing cancer treatment worldwide.
Advertisement
In-Article Ad
Scolyer's passing is a significant loss to the cancer research community and the many patients he inspired and helped.
Advertisement
In-Article Ad
Reader Poll
What do you think is the most important aspect of Richard Scolyer's legacy?
Connecting to poll...
Read the original article
Visit the source for the complete story.




